gefticip

Introduction to gefticip

Gefticip is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer cells have certain genetic mutations called EGFR mutations. This medicine is often prescribed to patients who have not undergone chemotherapy before.

Composition of gefticip

Gefticip contains the active ingredient Gefitinib, which is a type of drug known as an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth.

Uses of gefticip

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
• Specifically targets cancer with EGFR mutations
• Prescribed for patients who have not received prior chemotherapy

Side effects of gefticip

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of gefticip

Gefticip should not be used by individuals who do not have EGFR mutations. It is also not recommended for pregnant or breastfeeding women, those with severe liver or kidney disease, or individuals with a history of interstitial lung disease. If you are allergic to Gefitinib or any of its ingredients, you should avoid this medication.

How to Take gefticip

• Take 250 mg once daily
• Consume orally as a single tablet
• Take at the same time each day for consistency

Conclusion of gefticip

Gefticip is a targeted therapy for non-small cell lung cancer with specific genetic mutations. While it offers significant benefits, it is important to be aware of its side effects and take necessary precautions. Always follow your healthcare provider's instructions when taking this medication.